Related Experiment Video
Updated: Aug 7, 2026

Feeding of Ticks on Animals for Transmission and Xenodiagnosis in Lyme Disease Research
Published on: August 31, 2013
Host metalloproteinases in Lyme arthritis
L T Hu1, M A Eskildsen, C Masgala
1New England Medical Center, Boston, Massachusetts, USA.
Objective:
To assess the role of matrix metalloproteinases (MMPs) in cartilage and bone erosions in Lyme arthritis
Methods:
We examined synovial fluid from 10 patients with Lyme arthritis for the presence of MMP-2, MMP-3, MMP-9, and "aggrecanase" activity using gelatinolytic zymography and immunoblot analysis. We developed an in vitro model of Lyme arthritis using cartilage explants and observed changes in cartilage degradation in the presence of Borrelia burgdorferi and/or various protease inhibitors.
Results:
Synovial fluid from patients with Lyme arthritis was found to contain at least 3 MMPs: gelatinase A (MMP-2), stromelysin (MMP-3), and gelatinase B (MMP-9). In addition, there was evidence in 2 patients of "aggrecanase" activity not accounted for by the above enzymes. Infection of cartilage explants with B. burgdorferi resulted in induction of MMP-3, MMP-9, and "aggrecanase" activity. Increased induction of these enzymes by B. burgdorferi alone was not sufficient to cause cartilage destruction in the explants as measured by glycosaminoglycan (GAG) and hydroxyproline release. However, addition of plasminogen, which can act as an MMP activator, to cultures resulted in significant GAG and hydroxyproline release in the presence of B. burgdorferi. The MMP inhibitor batimastat significantly reduced the GAG release and completely inhibited the collagen degradation.
Conclusion:
MMPs are found in synovial fluids from patients with Lyme arthritis and are induced from cartilage tissue by the presence of B. burgdorferi. Inhibition of MMP activity prevents B. burgdorferi-induced cartilage degradation in vitro.
Insights
Matrix metalloproteinases (MMPs) are present in Lyme arthritis synovial fluid and induced by Borrelia burgdorferi. Inhibiting MMPs prevents cartilage damage in this Lyme arthritis model.
Area of Science:
- Biochemistry
- Immunology
- Rheumatology
Background:
- Lyme arthritis is characterized by joint inflammation and potential cartilage and bone erosion.
- Matrix metalloproteinases (MMPs) are implicated in the degradation of extracellular matrix components in arthritic conditions.
Purpose of the Study:
- To investigate the role of specific MMPs in the pathogenesis of cartilage and bone erosions in Lyme arthritis.
- To determine if Borrelia burgdorferi directly induces MMPs and subsequent cartilage degradation.
Main Methods:
- Synovial fluid analysis from Lyme arthritis patients for MMP-2, MMP-3, MMP-9, and aggrecanase activity.
- In vitro model using cartilage explants infected with Borrelia burgdorferi, with and without protease inhibitors and plasminogen.
Main Results:
- Synovial fluid contained MMP-2, MMP-3, and MMP-9; aggrecanase activity was also detected.
- Borrelia burgdorferi infection induced MMP-3, MMP-9, and aggrecanase activity in cartilage explants.
- Cartilage degradation (GAG and hydroxyproline release) occurred when plasminogen was added, and was significantly reduced by MMP inhibition (batimastat).
Conclusions:
- MMPs are present in Lyme arthritis synovial fluid and are upregulated by Borrelia burgdorferi in cartilage.
- MMP activity inhibition effectively prevents Borrelia burgdorferi-induced cartilage degradation in an in vitro model.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
Myasthenia Gravis ll: Pathophysiology

